Back to search

Belgium· BE-AMP-SAM370124-00

Paclitaxel Eugia 6 mg/ml

A paclitaxel product containing paclitaxel, registered in Belgium by Eugia Pharma (Malta). The same ATC class is registered in 16 of our 19 countries.

ATC L01CD01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedPaclitaxel Eugia 6 mg/mlATCL01CD01REGISTER NO.BE-AMP-SAM370124-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Paclitaxel is registered in 16 of 19 countries.

Countries holding a registration under ATC L01CD01 (paclitaxel), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose

Paclitaxel · ATC L01CD01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of paclitaxel costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.61 in Czechia to $19.82 in Switzerland — a ×32 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Paclitaxel · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$19.82
  • CZ Czechia$0.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Paclitaxel
Manufacturer
Eugia Pharma (Malta)
Country
Belgium (BE)
ATC code
L01CD01
ATC class
Paclitaxel
Defined daily dose
15 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0758854
  • be_apb
    2756179

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

651 interactions on record for paclitaxel.

Graded by severity as the source publishes them — 41 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Paclitaxel · interactions on record

651 records

  • 41 severe
  • 302 moderate
  • 17 minor
  • 291 info

Most severe, free to view

  • SaquinavirJ05AE01severe
  • IndinavirJ05AE02severe
  • RitonavirJ05AE03severe
  • NelfinavirJ05AE04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Paclitaxel in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All paclitaxel products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Apacross, Bugvi
  • Bulgaria · Алсикроса, Паклитаксел Акорд
  • Cyprus · Paclitaxel Accord, Paclitaxel Hospira
  • Czechia · Alsicrosa, Paclitaxel Ebewe
  • Germany · Apacross, Axitaxel
  • Denmark · Apacross, Bugvi
  • Estonia · Paclitaxel Accord, Paclitaxel Ebewe
  • Spain · Apacross, Bugvi
  • Finland · Apacross, Pacligen
  • France · Bugvi, Paclitaxel Ahcl
  • United Kingdom (Northern Ireland) · Apacross, Paclitaxel
  • Greece · Biotaxel, Paclitaxel Hospira
  • Croatia · Abutrax, Alsicrosa
  • Hungary · Bugvi, Paclitaxel Accord
  • Ireland · Apacross, Paclitaxel
  • Iceland · Abraxane, Apexelsin
  • Italy · Abutrax, Apacross
  • Liechtenstein · Abraxane, Apexelsin
  • Lithuania · Paclitaxel Accord, Paclitaxel Ebewe
  • Luxembourg · Bugvi, Paclitaxel Accord Healthcare
  • Latvia · Paclitaxel Accord, Paclitaxel Kabi
  • Malta · Paclitaxel Accord Healthcare, Paclitaxel Hospira
  • Netherlands · Abutrax, Apacross
  • Norway · Abraxane, Apacross
  • Poland · Paclitaxel Ebewe, Paclitaxel Kabi
  • Portugal · Apacross, Paclitaxel Accord
  • Romania · Bugvi, Paclitaxel Accord
  • Sweden · Apacross, Bugvi
  • Slovenia · Alsicrosa, Paclitaxin
  • Slovakia · Paclitaxel Accord, Paclitaxel Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e92bb6c6-2900-4058-8e8d-02dcce0ee18c
GET /v1/drugs/e92bb6c6-2900-4058-8e8d-02dcce0ee18c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Concentrate for solution for infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Paclitaxel Eugia 6 mg/ml",
  "name_fr": "Paclitaxel Eugia 6 mg/ml",
  "name_nl": "Paclitaxel Eugia 6 mg/ml",
  "amp_code": "SAM370124-00",
  "strengths": [
    "6.0000",
    "6.0000",
    "527.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Paclitaxel",
    "Anhydrous Ethanol",
    "Macrogolglycerol Ricinoleate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Paclitaxel",
  "authorisation_numbers": [
    "BE370124"
  ]
}

See everything about paclitaxel.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.